Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06089694 · ClinicalTrials.gov registry record
Crome/Cobalt Respiration Study
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- 61
- Enrollment target
NCT06089694 is a clinical trial that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 61 participants.
The verdict
NCT06089694 has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- 61 participants
- Enrollment target
Study Summary
The goal of this study is to compare measured respiration rates in various subject scenarios and use conditions between capnography and the Crome and Cobalt ICD and CRT-D MRI SureScan devices (derived using a Holter recorder).
Interventions
- DEVICE Enabling Sensor Research Holter Mode feature
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2023-11-21 |
| Est. Completion | 2024-06-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06089694
The ClinicalTrials.gov registry entry for NCT06089694 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Enabling Sensor Research Holter Mode feature is the first listed.
NCT06089694 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06089694 about?
NCT06089694 is a clinical study titled "Crome/Cobalt Respiration Study". The goal of this study is to compare measured respiration rates in various subject scenarios and use conditions between capnography and the Crome and Cobalt ICD and CRT-D MRI SureScan devices (derived using a Holter recorder).
What is the current status of trial NCT06089694?
This trial is currently completed. The enrollment target is 61 participants. The study started on 2023-11-21. Estimated completion is 2024-06-12.
What interventions are being tested in trial NCT06089694?
The interventions under investigation include: Enabling Sensor Research Holter Mode feature (DEVICE).
Who is sponsoring clinical trial NCT06089694?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.